Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA249111
Max Phase: Preclinical
Molecular Formula: C27H32N6O3S
Molecular Weight: 520.66
Molecule Type: Small molecule
Associated Items:
ID: ALA249111
Max Phase: Preclinical
Molecular Formula: C27H32N6O3S
Molecular Weight: 520.66
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(C)=O)c2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc5nsnc5n4)CC3)CN(C)[C@@H]1C2
Standard InChI: InChI=1S/C27H32N6O3S/c1-16(34)19-4-6-24(36-3)21-13-17-12-18(15-31(2)23(17)14-20(19)21)27(35)33-10-8-32(9-11-33)25-7-5-22-26(28-25)30-37-29-22/h4-7,17-18,23H,8-15H2,1-3H3/t17-,18-,23-/m1/s1
Standard InChI Key: GBBWPPZDGCIUKR-PMAPCBKXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 520.66 | Molecular Weight (Monoisotopic): 520.2257 | AlogP: 2.68 | #Rotatable Bonds: 4 |
Polar Surface Area: 91.76 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 8.30 | CX LogP: 3.09 | CX LogD: 2.13 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.49 | Np Likeness Score: -0.64 |
1. Troxler T, Hoyer D, Langenegger D, Neumann P, Pfäffli P, Schoeffter P, Sorg D, Swoboda R, Hurth K.. (2007) Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists., 17 (14): [PMID:17507221] [10.1016/j.bmcl.2007.04.086] |
Source(1):